Adalat LA 30mg Prolonged-Release Tablet

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Aktīvā sastāvdaļa:

Nifedipine

Pieejams no:

Imbat Limited

ATĶ kods:

C08CA; C08CA05

SNN (starptautisko nepatentēto nosaukumu):

Nifedipine

Deva:

30 milligram(s)

Zāļu forma:

Prolonged-release tablet

Receptes veids:

Product subject to prescription which may be renewed (B)

Ārstniecības joma:

Dihydropyridine derivatives; nifedipine

Autorizācija statuss:

Authorised

Autorizācija datums:

2009-06-19

Lietošanas instrukcija

Page 1 of 2
PACKAGE LEAFLET: INFORMATION FOR THE USER
ADALAT
® LA 30MG PROLONGED-RELEASE TABLET
(nifedipine)
Your medicine is available using the name Adalat LA 30mg
Prolonged-Release Tablet but will be referred to as Adalat LA
throughout this leaflet.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE.

Keep this leaflet. You may need to read it again.

If you have more questions, ask your doctor or
pharmacist.

This medicine has been prescribed for you. Do not pass
it on to others. It may harm them, even if their
symptoms are the same as yours.

If any of the side effects gets serious, or if you notice
any side effects not listed in this leaflet, please tell your
doctor or pharmacist.
IN THIS LEAFLET
1.
What Adalat LA is
2.
Before you take Adalat LA
3.
How you take Adalat LA
4.
Possible side effects
5.
How to store Adalat LA
6.
Contents of the pack and other information
1.
WHAT ADALAT LA IS
Adalat LA contains nifedipine, which belongs to a group of
medicines called _calcium antagonists._
ADALAT LA IS USED TO TREAT HIGH BLOOD PRESSURE OR ANGINA
_(chest pain). _
For high blood pressure: Adalat LA works by relaxing and
expanding the blood vessels. This makes the blood flow more
easily and lowers blood pressure. Lower blood pressure
reduces the strain on your heart.
For angina: Adalat LA works by relaxing and expanding the
arteries supplying the heart. This allows more blood and
oxygen to reach the heart and decreases the strain on it. Your
angina attacks will be less severe and less frequent if there is
less strain on the heart.
2.
BEFORE YOU TAKE ADALAT LA
DO NOT TAKE ADALAT LA:

IF YOU HAVE HAD A HEART ATTACK within the last month.

IF YOU GET A SUDDEN ANGINA ATTACK. Adalat LA will not
help relieve symptoms of angina quickly.

IF YOU HAVE UNSTABLE ANGINA.

IF YOU ARE ALLERGIC to the active ingredient (nifedipine),
to any other similar medicines (known as
d_ihydropyridines) _or to any of the other ingredients. The
ingredients of Adalat LA are listed in section 6.


Produkta apraksts

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Adalat LA 30mg Prolonged-Release Tablet
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One tablet contains 30 mg nifedipine.
Excipient with known effect: Sodium
For a full list of excipients, see Section 6.1.
3 PHARMACEUTICAL FORM
Prolonged-release film-coated tablet.
_Product imported from the UK, Romania and Spain:_
Pink, circular, convex tablets with 'Adalat 30'
marked on one side and plain on the reverse.
4 CLINICAL PARTICULARS
As per PA1410/025/006
5 PHARMACOLOGICAL PROPERTIES
As per PA1410/025/006
6 PHARMACEUTICAL PARTICULARS
6.1 LIST OF EXCIPIENTS
_Product imported from the UK and Romania:_
Polyethylene oxide
Hypromellose
Magnesium stearate
Sodium chloride
Cellulose acetate
Macrogol
Hydroxypropylcellulose
Propylene glycol
Titanium dioxide (E171)
Iron oxide (E172)
Shellac*
(* in product sourced from the UK only).
_Product imported from Spain:_
Polyethylene oxide
Hypromellose
Magnesium stearate
Sodium chloride
Red iron oxide (E172)
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_6_
_/_
_0_
_6_
_/_
_2_
_0_
_1_
_8_
_C_
_R_
_N_
_ _
_2_
_2_
_0_
_8_
_6_
_8_
_2_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
Cellulose acetate
Macrogol
Hydroxypropylcellulose
Propylene glycol
Titanium dioxide (E171)
Black iron oxide (E172)
6.2 INCOMPATIBILITIES
Not applicable
6.3 SHELF LIFE
The shelf life expiry date of this product is the date shown on the
blister strips and outer carton of the product as
marketed in the cou